ABA Sleep Medicine flashcards
ABA Sleep Medicine · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Sleep efficiency
- Total sleep time divided by time in bed, multiplied by 100 to give a percentage; values below about 85% suggest poor sleep continuity.
- Slow-wave sleep
- Stage N3 sleep, defined by >20% of an epoch containing 0.5-2 Hz waves with amplitude >75 µV; predominates early in the night.
- REM sleep features
- Mixed-frequency low-amplitude EEG, rapid eye movements, and lowest chin EMG tone; REM periods lengthen toward morning.
- Sleep spindle
- A train of 11-16 Hz waves lasting ≥0.5 seconds, a hallmark of stage N2 sleep; helps define N2 onset.
- K-complex
- A well-delineated negative sharp wave followed by a positive component lasting ≥0.5 seconds; marks stage N2 sleep.
- Dim light melatonin onset
- The time melatonin rises in dim light, marking circadian phase; typically occurs 2-3 hours before habitual sleep onset.
- Delayed sleep phase disorder
- Sleep-wake timing delayed >2 hours relative to desired schedule, with normal sleep duration when unconstrained; common in adolescents.
- Advanced sleep phase disorder
- Sleep onset and wake times shifted earlier than desired, often in older adults, with early evening sleepiness and early morning awakening.
- Non-24-hour rhythm disorder
- A circadian rhythm slightly longer than 24 hours causing progressive drift in sleep timing; most common in totally blind individuals.
- Apnea-hypopnea index
- The number of apneas plus hypopneas per hour of sleep; ≥5 with symptoms or ≥15 alone diagnoses obstructive sleep apnea.
- Cheyne-Stokes respiration
- Cyclical crescendo-decrescendo breathing with central apneas, often seen in heart failure and associated with poor prognosis.
- Obesity hypoventilation syndrome
- BMI ≥30 with awake PaCO2 >45 mmHg and no other cause of hypoventilation; often coexists with obstructive sleep apnea.
- CPAP adherence threshold
- Commonly defined as CPAP use ≥4 hours per night on ≥70% of nights; below this, benefit and reimbursement criteria may not be met.
- STOP-BANG questionnaire
- An eight-item screening tool for OSA risk; a score ≥3 indicates elevated risk and warrants further evaluation.
- Chronic insomnia disorder
- Difficulty initiating or maintaining sleep ≥3 nights per week for ≥3 months with associated daytime impairment.
- CBT-I components
- Cognitive behavioral therapy for insomnia includes stimulus control, sleep restriction, cognitive restructuring, and relaxation; first-line for chronic insomnia.
- Narcolepsy type 1
- Excessive daytime sleepiness with cataplexy and/or CSF hypocretin-1 ≤110 pg/mL, reflecting orexin neuron loss.
- Multiple sleep latency test
- Four to five nap opportunities after overnight polysomnography; mean sleep latency ≤8 minutes plus ≥2 sleep-onset REM periods supports narcolepsy.
- Idiopathic hypersomnia
- Excessive daytime sleepiness with long unrefreshing naps and no sleep-onset REM periods; hypocretin is normal.
- Restless legs syndrome
- An urge to move the legs, worse at rest and in the evening, relieved by movement; diagnosis is clinical.
- Periodic limb movements
- Repetitive limb movements lasting 0.5-10 seconds, often in series of ≥4, scored during polysomnography.
- REM sleep behavior disorder
- Dream enactment with loss of normal REM atonia; strongly associated with later synucleinopathies such as Parkinson disease.
- Disorders of arousal
- NREM parasomnias including confusional arousals, sleepwalking, and sleep terrors, arising mainly from slow-wave sleep.
- Polysomnography channels
- Standard recording includes EEG, EOG, chin EMG, ECG, airflow, respiratory effort, oxygen saturation, and limb EMG.
- Home sleep apnea test
- A limited-channel study used in adults with high pretest probability of moderate to severe OSA and no major comorbidity.
- Arousal scoring rule
- An abrupt EEG frequency shift lasting ≥3 seconds, with or without increased EMG, used to score arousals.
- Maintenance of wakefulness test
- Measures ability to remain awake in a quiet, dimly lit setting; used in safety-sensitive and treatment-response contexts.
- Perioperative OSA risk
- Untreated OSA increases difficult airway, postoperative desaturation, and cardiopulmonary complications; CPAP should generally continue when feasible.
- ICU sleep disruption
- Critical illness causes fragmented sleep with reduced REM and circadian disruption due to noise, light, and frequent interruptions.
- Opioid effects on breathing
- Opioids depress ventilatory drive and airway tone, potentially causing central apnea and ataxic breathing patterns.
- Pediatric OSA causes
- Adenotonsillar hypertrophy is the most common cause; adenotonsillectomy is often first-line treatment in children.
- OSA comorbidities
- Obstructive sleep apnea is associated with resistant hypertension, atrial fibrillation, stroke, and heart failure.